Your session is about to expire
← Back to Search
Behavioral Intervention
Transcranial Magnetic Stimulation + Episodic Future Thinking for Methamphetamine Addiction
N/A
Waitlist Available
Led By Heather Webber, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Personal history of epilepsy or seizure disorder
Moderate-to-severe heart disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7-day follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to compare the effects of repetitive transcranial magnetic stimulation (rTMS) with Episodic Future Thinking (EFT) versus a placebo treatment on impulsive decision-making, drug
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a history of epilepsy or seizures.
Select...
I have moderate to severe heart disease.
Select...
I am not on medications that are unsafe or increase seizure risk.
Select...
I have had a serious head injury where I lost consciousness.
Select...
I cannot read, write, or speak English.
Select...
I have had brain surgery in the past.
Select...
I have had a stroke in the past.
Select...
I have had a brain lesion or condition causing increased pressure in my head.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7-day follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7-day follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in MA Demand as assessed by the Drug Purchasing Task
EFT Engagement as assessed by the Engagement Scale
EFT Vividness as assessed by the Vividness Scale
+1 moreSecondary study objectives
Change in prospective memory (PM) as assessed by the behavioral PM task
Change in prospective memory as assessed by the Prospective and Retrospective Memory Questionnaire (PRMQ)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: highfrequency rTMS+EFTExperimental Treatment2 Interventions
Group II: sham rTMS+EFTPlacebo Group2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EFT
2023
N/A
~140
high frequency rTMS
2016
N/A
~20
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
956 Previous Clinical Trials
346,036 Total Patients Enrolled
Heather Webber, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
4 Previous Clinical Trials
108 Total Patients Enrolled